TPCW
CERE

TD Private Client Wealth’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

TD Private Client Wealth’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-78
Closed -$3.19K – 1302
2024
Q2 		$3.19K Buy
+78
New +$3.19K ﹤0.01% 1113